Hematologic Malignancies Stocks List

Recent Signals

Date Stock Signal Type
2021-04-14 AFMD Upper Bollinger Band Walk Strength
2021-04-14 AFMD New 52 Week High Strength
2021-04-14 AFMD New 52 Week Closing High Bullish
2021-04-14 APTO 200 DMA Support Bullish
2021-04-14 APTO Crossed Above 20 DMA Bullish
2021-04-14 CLLS Shooting Star Candlestick Bearish
2021-04-14 CLLS 180 Bearish Setup Bearish Swing Setup
2021-04-14 CLLS 20 DMA Resistance Bearish
2021-04-14 CLLS Bollinger Band Squeeze Range Contraction
2021-04-14 FATE Crossed Above 20 DMA Bullish
2021-04-14 IDRA New 52 Week Low Weakness
2021-04-14 IDRA Narrow Range Bar Range Contraction
2021-04-14 IDRA New 52 Week Closing Low Bearish
2021-04-14 INCY Crossed Above 50 DMA Bullish
2021-04-14 INCY Crossed Above 20 DMA Bullish
2021-04-14 INMB Slingshot Bearish Bearish Swing Setup
2021-04-14 KYMR MACD Bullish Signal Line Cross Bullish
2021-04-14 KYMR Slingshot Bearish Bearish Swing Setup
2021-04-14 PRTC Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-04-14 PRTC Narrow Range Bar Range Contraction
2021-04-14 PRTC Hammer Candlestick Bullish
2021-04-14 PRTC Doji - Bullish? Reversal
2021-04-14 SGEN Crossed Above 20 DMA Bullish
2021-04-14 SGEN Bollinger Band Squeeze Range Contraction
2021-04-14 SLS 180 Bearish Setup Bearish Swing Setup

Recent News for Hematologic Malignancies Stocks

Date Stock Title
Apr 14 KYMR Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
Apr 13 INFI FibroGen (FGEN) DMD Drug Pamrevlumab Gets FDA's Fast Track Tag
Apr 13 INCY Incyte to Report First Quarter Financial Results
Apr 13 FATE Cathie Wood Buys Yet Another Workhorse Dip, Also Adds DraftKings, Peloton, Square
Apr 12 KYMR Kymera Therapeutics (KYMR) Presents At AACR Virtual Meeting 2021 - Slideshow
Apr 12 INCY Incyte Corporation (INCY) Presents at AACR Virtual Meeting 2021 - Slideshow
Apr 12 AFMD Company News for Apr 12, 2021
Apr 12 PRTC PureTech Presents Promising Preclinical Data from LYT-210 Immuno-Oncology Program at American Association for Cancer Research (AACR) Annual Meeting
Apr 12 AFMD Affimed shares gain 5% on encouraging AFM24 data in EGFR-expressing solid tumors
Apr 12 AFMD Affimed Highlights the Potential of its Innate Cell Engager AFM24 as EGFR-targeting Therapy for Solid Tumors as Monotherapy and in Combination with Adoptive NK Cell Transfer at AACR Virtual Annual Meeting I
Apr 12 AFMD 51 Biggest Movers From Friday
Apr 12 SGEN Seagen: The New Oncology Hope
Apr 10 AFMD The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
Apr 10 KYMR Kymera Therapeutics Presents Late-Breaking Preclinical Data Highlighting Superiority of Dual-Targeting Activity of IRAKIMiD Degrader KT-413 at AACR Annual Meeting 2021
Apr 9 INMB Inmune Bio files to sell 1.7M shares from shareholder Xencor
Apr 9 SGEN FDA accepts Genmab, Seagen's tisotumab vedotin BLA application for review
Apr 9 SGEN Seagen and Genmab Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
Apr 9 SGEN Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
Apr 9 AFMD Here's Why Shares of Affimed Skyrocketed Today
Apr 9 AFMD Mid-Afternoon Market Update: Dow Surges Over 100 Points; Provention Bio Shares Plunge
Related Industries: Biotechnology